Application of hydroxyapatite nanoparticles in development of an enhanced formulation for delivering sustained release of triamcinolone acetonide
Saeid Koocheki1, Sayed Siavash Madaeni1, Parisa Niroomandi21Membrane Research Center, Chemical Engineering Department, Razi University, Kermanshah, Iran; 2Exir Pharmaceutical Co, Lorestan, Boroujerd, IranAbstract: We report an analysis of in vitro and in vivo drug release from an in situ formulation...
Guardado en:
Autores principales: | Koocheki S, Madaeni SS, Niroomandi P |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/94ce7bef376245538288223e4a67a2e5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Transdermal permeability of triamcinolone acetonide lipid nanoparticles
por: Qin ZM, et al.
Publicado: (2019) -
Sterile endophthalmitis rates and particle size analyses of different formulations of triamcinolone acetonide
por: Dodwell DG, et al.
Publicado: (2015) -
Trabeculectomy with intraoperative retrobulbar triamcinolone acetonide
por: Malik Y Kahook, et al.
Publicado: (2008) -
EFFECT OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN REFRACTORY DIABETIC MACULAR EDEMA
por: Ume Sughra, et al.
Publicado: (2021) -
Long-Term Outcomes of Macular Hole Repair with Triamcinolone Acetonide Visualization
por: Wallsh J, et al.
Publicado: (2021)